Aura, Cabaletta Complete Major Public Offerings This Week
PUBLISHED May 4, 2026, 6:56 AM ET
Read, Watch or Listen
Boston — Aura Biosciences announced on May 4 that it priced an underwritten public offering of common stock and pre-funded warrants, offering 39,591,000 shares and up to 3,800,000 pre-funded warrants at $6.00 and $5.99999 respectively; the company granted underwriters a 30-day option for additional shares. Boston and Philadelphia reports this week show related financing activity in the biotech sector: Aura reported the offering closed on May 5 with full exercise of the underwriters’ option, generating approximately $299.4 million in gross proceeds, while Cabaletta priced an at-the-market offering on May 4 expected to raise about $150 million with institutional participation, including Eli Lilly.
By James Porter | JQJO News
Timeline of Events
- May 4, 2026 — Aura announced launch of an underwritten public offering via GlobeNewswire.
- May 4, 2026 — Cabaletta Bio priced an at-the-market offering expected to raise about $150 million.
- May 4, 2026 — Aura priced 39,591,000 shares and up to 3,800,000 pre-funded warrants at $6.00/$5.99999.
- May 5, 2026 — Aura closed the offering, with underwriters fully exercising the option; gross proceeds about $299.4 million.
- May 5–6, 2026 — News outlets published the pricing and closing notices, listing underwriters and participating investors.
News Intelligence
- These public offerings by Aura and Cabaletta are big moves in the biotech sector. They show investor confidence, which can influence the stock market. If you're invested in biotech or considering it, keep an eye on these companies.
- Articles Published:
- 4
- Right Leaning:
- 0
- Left Leaning:
- 0
- Neutral:
- 4
- Distribution:
- Left 0%, Center 100%, Right 0%
Aura Biosciences and Cabaletta Bio obtained new capital from institutional and strategic investors, while underwriters and participating investment firms earned underwriting fees and placement allocations.
Existing common shareholders of Aura experienced dilution as the company issued additional common shares and pre-funded warrants, reducing existing ownership percentages.
Coverage of Story:
From Left
No left-leaning sources found for this story.
From Center
Aura, Cabaletta Complete Major Public Offerings This Week
Taiwan News Weekly Voice Taiwan News Taiwan NewsFrom Right
No right-leaning sources found for this story.
Comments